Ocrelizumab is noninferior to fingolimod, demonstrating efficacy and safety in children and adolescents with ...

Leber hereditary optic neuropathy (LHON) is a genetic mitochondrial disorder that damages retinal ganglion cells, resulting in rapid vision loss. Idebenone is expected to restore mitochondrial ...

The FDA has extended the review period of the New Drug Application for tolebrutinib for the treatment of non-relapsing, secondary progressive MS and to slow disability accumulation independent of ...

A decades-old cancer drug may soon be approved to help kids with certain autism-related symptoms linked to folate deficiency.

Estrogen therapy may reduce Alzheimer disease risk, with lower risk seen in association with early initiation.

Cocoa extract supplementation yields a reduction in high-sensitivity C-reactive protein and an increase in interferon-γ.

Shunt surgery significantly improves gait velocity at three months among patients with idiopathic normal-pressure hydrocephalus with a response to temporary CSF drainage.

Dementia risk in type 2 diabetes varies by treatment, with some metformin-based combination therapies offering greater protection.

Daily treatment with atogepant maintains long-term safety, efficacy, and functional benefits over 1 year in patients with chronic and episodic migraine.

After menopause, women with MS show accelerated loss of volume in brain structures associated with memory, attention, and problem-solving.

Elevated vitamin D levels may lower the risk for MS in White individuals, though this association is less pronounced in Black ...

A new federal vaccine panel appointed by US Health Secretary Robert F Kennedy Jr has recommended tighter restrictions on COVID-19 vaccines.